TIL
Instil Bio
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
TIL Profile
Instil Bio, Inc.
A clinical-stage biopharmaceutical company that focused on developing tumor infiltrating lymphocyte therapies for cancer
Biological Technology
Invalid Date
03/19/2021
NASDAQ Stock Exchange
14
12-31
Common stock
3963 Maple Avenue, Suite 350, Dallas, Texas 75219
--
Instil Bio, Inc., headquartered in Dallas, Texas, was incorporated in Delaware in August 2018. The Company is a clinical-stage biopharmaceutical company developing innovative autologous tumor infiltrating lymphocyte (TIL) therapeutic cell therapies to treat cancer patients.